drugset / Trial / NCT04252885
The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
The study explores the efficacy of lopinavir plus ritonavir and arbidol in treating with novel coronavirus infection. As a result this study would provide evidence for the clinical usage of these drugs in the future .
Timeline
- Start
- 2020-01-28
- Primary completion
- 2020-04-30
- Completion
- 2020-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir | Other / unclassified | 200 mg | Oral |
| Subject | Ritonavir | Other / unclassified | 50 mg | Oral |
| Comparator | Umifenovir | Small molecule | 200 mg | Oral |